• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

HYPITAT-II: Immediate Delivery or Expectant Management for Non-Severe Hypertension at 34 – 37 weeks?

image_pdfFavoriteLoadingFavorite

FINDINGS:

Women between 34 0/7  through 36 6/7 gestational weeks with non-severe hypertensive disorders such as (1) gestational hypertension, (2) pre-eclampsia, (3) deteriorating pre-existing hypertension or superimposed pre-eclampsia were studied to determine if they should be delivered immediately or followed with close monitoring.  The results of the study showed:

  • There was no statistical risk reduction in adverse maternal outcomes in women who were delivered immediately (1.1%) compared to expectant management (3.1%)
  • Maternal adverse events overall, such as thromboembolic disease, pulmonary edema and eclampsia, were relatively uncommon
  • There was an increase in neonatal respiratory distress syndrome in the immediate delivery group (5.7%) compared to the expectant management group (1.7%) that was statistically significant (P=0.005) which required treatment with continuous positive airway pressure and/or surfactant
  • Based on these findings, routine immediate delivery does not appear justified and expectant monitoring through 36 5/7 gestational weeks should be considered  

SYNOPSIS:

In a multi-centered randomized controlled trial published in the Lancet (2015), investigators sought to determine the risks/benefits of immediate delivery compared to expectant monitoring in pregnancies between 34 and 37 weeks gestational age, following their initial study that demonstrated induction of labor compared to expectant monitoring  after 37 0/7 weeks gestational age did reduce maternal harms but did not affect neonatal outcomes nor increase cesarean section rates (Lancet, 2009).

KEY POINTS:

  • Hypertensive disorders in pregnancy are common and can occur in up to 10% of all pregnancies
  • In the case of non-severe hypertensive disorders, there does not appear to be sufficient  benefit to delivery before 37 weeks gestation while there is risk of respiratory distress syndrome to the newborn

Learn More – Primary Sources:

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomized controlled trial

Induction of labor versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicenter, open-label randomized controlled trial

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site